LENZ Therapeutics (NASDAQ:LENZ) said Monday that CORXEL Pharmaceuticals has submitted the new drug application for LNZ100 to the Center for Drug Evaluation of the National Medical Products ...

LENZ Therapeutics previously licensed Greater China rights to CORXEL for the development and commercialization of LNZ100 in April 2022.

A top-performing Greater China equity fund manager is sticking with his conviction call on big Chinese bank stocks listed in ...

While Greater China continues to weigh heavily on first-half results, the group said it saw positive signs there, while other ...

Distribution: North America is home to 43.2% of the world’s millionaires, followed by Western Europe (26.2%), Greater China ...

China’s trade with the world is within reasonable bounds and the nation isn’t out to dominate global markets, a senior ...

From planning to execution, three conference team members share reflections on fostering understanding, sparking collaboration and shaping forward-looking ideas.

ZEISS Group has named Martin Fischer as the new President and CEO of ZEISS Greater China, effective October 2025. Succeeding ...

A&O Shearman also did not make any Greater China lawyers partners in 2025. In fact, in the last two rounds of annual partner promotions, Clifford Chance was the only top U.K. firm to have promoted ...

Swatch's sales fell more than expected in the first half of 2025, the company said on Thursday, as the Swiss watchmaker faced ...